Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree 123! This board should be open, and about free expressions of opinion and ideas. Hence, this should be the board's culture without the expectancy of petards of harsh criticism being hurled in response to freedom of expression. It should be all business not personal!
GLTA!!!
There are ebbs and flows in the life of all companies. Hence, due to changing market trends and a whole host of other unforeseen occurrences. The vagaries of existing as a company, or even as a person, is forever with us. But let's not get too far afield away from the subject. Thus, I would posit, Mr. Sculley shouldn't have to convince anybody of his marketing abilities, thus, with having two huge success stories in his portfolio.
GLTA!!! And As Always, Go BIEL!!!!!
To rephrase my earlier post, for some may have misinterpreted it.
Restated: RE:bieliever post# 147857:... Well, why not? If Keith feels that way, well, that kind of thinking is what holds a lot of us back. John Sculley probably has forgotten more marketing techniques than Keith is even aware of. If you have an able and willing resource like a John Sculley, heck, you make use of it!!
GLTA!!!
Marketing is king people! Need I Say More!!!
GLTA!!!
Well, why not? John Sculley probably has forgotten more marketing techniques than Keith is even aware of. See, that kind of thinking is what holds a lot of us back. If you have an able and willing resource like a John Sculley, heck, you make use of it!!
GLTA!!!
John Sculley, of Pepsi and Apple CEO fame, is someone from which BIEL needs to seek services. Or, maybe create something like an emeritus position within the organization so he can school young marketing pups like Keith. I betcha Sculley would turn these BIEL marketing woes around in no time flat. There is a very high probability he could pull it off because he has done it before, in big, big, ways... à la, Pepsi and Apple! Just John Sculley's name alone associated with company is worth 10 cents!
Right Of The Bat!!
GLTA !!!
P.S. BIEL, now you have the road map, take it!!!!!!!!
John Sculley, once Pepsi and Apple CEO discussed on TV today two very interesting business concepts, with which I wholeheartedly agree. He said while at Pepsi, they successfully competed with Coke by implementing the concept of "Owning The Experience Marketing". He also talked about a Chinese marketing concept which Americans haven't learned how to do yet, and that's "Speed Of Scale Marketing". Bang! Bang! That is exactly what BIEL needs at this juncture. Oh, yah! That's the guy BIEL needs to hire! Stop all this Pussyfooting around!
GLTA!!!
Hate to tell you this, but this bag of bones is dead and gone! The last rites have been read. That's it!
P.S. Hey! What happened to the stock status window? Well, I guess that indicates the janitor has left the building too! As I said, it's finished! Gone! kaput!
GLTA!!!
That's the last thing you should want to happen; a buyout by a Big Pharma company like Bayer. However, companies like Google, Amazon, Microsoft, and maybe a few other non-drug firms, IMO, would be better steward for BIEL's fantastic product. The aforementioned are so wealthy, they can fight out any political, or market obstacles. I would be hard pressed to trust a drug company to go hard and heavy to have Actipatch to be a household name, as a non-drug analgesic. Actipatch is a nemesis to them, so why would anyone think they would go all out to promote it, and sustain it? Hey! They just might try to bury it! Well, that's my Take!!
GLTA!!!
If I've said it once, I've said it a million times. There are technical reasons why this stock won't move in a significant upward trend. We all should understand that by this point. There are professional stock hunters(individual and institutional) aplenty out there, and they are just chomping at the bit to glom onto the next big blockbuster. Does anyone think it would take them more than 10 years to get wind of BIEL? Oh, Come On! You can bet these stock chasers examine the fundamentals associated with target firms, which include the management functions, no doubt.
I ain't saying, I'm just Saying!
Well, That's My Take!!
GLTA!!! As Always, Go BIEL!!!
AW says he is expecting a 3 month wait, from date of submission. Maybe he should be the "hour class" source for this FDA response timetable!
GLTA!!!
So, where is the exposure?! All I essentially see is a big 'ol nothing burger, when it come to exposure! Yah know! Sometimes you have to make your own exposure. Don't wait for others to toot your horn, get out front yourself. People, companies, etc., have been doing it for many, many, years, or do I have it wrong? But then again, there is a reason why they are not tooting. As I have said before, I guess we will have to just wait see the end game results.
GLTA!!!
Very good points '43! Also, I would like to make the following points. Thus, a respectable AD campaign could be leveraged, IMO, with minimal risk. The revenue return as a result of effective advertising would have the subject company in the black pretty quickly, I would think. So, this calculated strategy of lying low in the weeds, up to this point at least, is being orchestrated by BIEL for reasons they only know. So, I guess we outsiders are positioned only to look through BIEL's Class Darkly and hope for the best.
GLTA!!! And Go BILE!!
Hey! As reported on this board, Mr. AW, himself stated that he expects the FDA response to BIEL's 510(k) would materialize in 3 months. So, maybe you should take the man at his word!
GLTA!!!
Recently, it was reported on this board that AW admitted to filing a traditional 510(k), as oppose to an Expedited one. So why take the extended route instead of a potentially short one? Hmm! BIEL has been trying to get to this point regarding full clearance for more than 10 years. So why are they dragging their feet at this stage of the saga? As I have stated in an earlier post, thus, BIEL doesn't seem to want the company/stock to explode at this particular time. Why?!!!! I think something is up, but what? That's my take!
As Always, Go BIEL!!!
GLTA!!!
"BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio"
Another news plash and nothing happens; BIEL stock is still in the ditch. I contend that it will never move in a significant upward trend until the share structure improves. When the FDA finally approves full clearance soon, it will be interesting to witness the movement of the stock. Of course, it will experience a minor spike, but will fall back as it has done time and time again. I might be wrong, but I don't think so. Nonetheless, go BIEL!
GLTA!!!
P.S. AW, please get on your horse and Fix The Share Structure!
Oh, Really! Who cares!
I agree CC! This product is an altogether different animal!
GLTA!!!
When the FDA awards BIEL clearance for its Full Body Musculoskeletal Pain Relief device, the aftermath will be quite interesting. I'm a firm believer that structural fundamentals of a company deemed positive, or, negative, dictate the PPS behavior of its stock. Again, it will be extremely interesting to witness the behavior of BIEL's stock when the FDA eventually awards clearance. My position on fundamentals maybe all wet regarding this case, but I don't think so!
GLTA!!!
Jay, thanks for the update! Great News!!
Hmm! Kinda curious why BIEL is holding off on filing for FDA Full Clearance for Actipatch.
GLTA!!!
First of all, you will have to define a "True Long" for me. Secondly, of course, an extensive advertisement campaign is very costly, but that can be underwritten by an outside financial source. With a product like Actipatch (i.e., monster in your pocket product), you can't tell me that BIEL can't find an investment source willing to foot the bill for an AD campaign. I don't think the campaign needs to be world class, if you know what I mean. Also, we are told that BIEL has partners all over the world and what's curious, to my knowledge, not one of them is advertising Actipatch on a serious scale. What! Why? At this juncture in healthcare history, in particular, the issue with the pain medication crisis, Actipatch appears to be a God-sent. So, why BIEL isn't screaming this at the top of their voice, as loudly as possible? Well, that's the salient question! Furthermore, regarding the FDA being a stick-in-the-mud when it come to issuing clearance for BIEL, well, a little bit advertisement would go a long way to put pressure on the FDA to move in BIEL's favor. With the public having knowledge of a strong (do no harm) alternative to pain medications, the FDA would be forced to get off its butt and do the right thing; thus, issue a full clearance for Actipatch. That's My Take!
GLTA!!!
P.S. I agree, we will most surely get there, but what's currently going on is quite strange.
Logic Rules!
Well, From my vantage point, it's obvious BIEL is complicit in suppressing the stock's PPS. Thus, no advertisement, concealing what surely would be positive PRs. So, why are they doing this?
"It is a riddle, wrapped in a mystery, inside an enigma."
- Winston Churchill -
let's hope that everything turns out ok, for everybody.
GLTA!!!
I agree Free! BIEL seems to be complicit in holding this rearing steed back from bolting ahead and reaching high expectations. It is very, very, strange! But make no mistake about it, this is intentional. IMO, it's an ongoing strategy which BIEL has implemented for a while now. To what end, well your guess is as good as mine. I do have a theory why they are doing this, but only that, a theory. So I'll keep that supposition to myself for now. However, I've posted my opinion on this very subject in the past. But I care not to revisit it at this time.
GLTA!!! And Go BIEL!!!
Why isn't there a date on that PR? Maybe it's not that important but date omission, relative to just about anything, is one of my most annoying pet peeves.
GLTA!!!
“All courses of action are risky, so prudence is not in avoiding danger (it's impossible), but calculating risk and acting decisively. Make mistakes of ambition and not mistakes of sloth. Develop the strength to do bold things, not the strength to suffer.”
- Niccolò Machiavelli -
With the above quote withstanding to whatever degree, as shareholders we are obliged to be informed and register critiques.
Go, BIEL!!!
When did Mundipharma buy the Distribution Rights?
Are you joking!
JGD, I get it! BIEL has done well, as of late. As I understand it, BIEL has been around for more than 10 years. So, don't you think they should be in full bloom as a business concern, or pretty close to it by now? I know, lucky for us investors they have been a little slow off the mark. But, nonetheless, opportunity waits for no one, so the sooner BIEL gets its machinery going in high gear, the better. They will have serious competitors snapping at their heels soon enough. I'm not smashing BIEL, but posing questions relative to my observations. Hey people! Don't Worry! BIEL is solid enough to weather a bit of scrutiny. In fact, as shareholder, we should be the first to register tough questions for BIEL's officials.
GLTA!!! And of course, Go BIEL!!!
Oh, come on! Sorry, but that poor-boy song... but we ain't got no money routine just won't cut. This is a choice which the CEO has made, for whatever reason. If a CEO of a company which has an all but certain monster of a product securely stuffed in his back pocket, but can't find an outside cash resource to underwriter one of his company's most important business functions, then, oh well.
GLTA!!!
P.S. The universe functions on logic! It might be a good idea if we do the same!
Why continue to dilute this way? BIEL could have leveraged an AD campaign to get the word out for its product(s) a long time ago, but chose not to do so. One must ask, Why? It would be tough to convince me that a company with this kind of "crazy" potential couldn't, or can't find a financial backer to underwriting it's promotional activities. As a business, if the majority of the public doesn't know you exist, then how do you expect to sell your product to them, on a mass scale? It's not going to happen! Hence, you don't make money, so you dilute your bleeping A%# O@#. It makes no sense! So why are they doing this? I hope it's not incompetence, but a shrewd plan for whatever reason to affect a positive outcome for the company and its shareholders. Can't imagine what that "Rube Goldberg" scheme could be, but hopefully things will work out.
GLTA!!! & Go BIEL!!!
P.S. Someone should tell that Jolly guy to ask more important questions like, why aren't you advertising? It would be interesting to hear what the answer would be. Sir, we don't have money won't be a good answer!
It's basic why this stock doesn't move, even amid great press. This stock want advance, in a significantly upward trend, until its structural fundamentals improve. That's It! We can engage in wishful thinking, but I think most of us on this board know what the truth is regarding this situation, if we are honest with ourselves. From my vantage point, the quickest way to get from under this 25B dilution anvil, is to have a "Big Boy" business concern to execute a buyout of BIEL. Then subsequently, wage an aggressive stock buy back campaign. Otherwise, we are looking at a number of years before we see BIEL's stock grow in a manner, in which we expect and deserve.
GLTA!!!
No doubt, this stock is being held back, but for what reason? To be sure, BIEL is not doing its very best to get the stock out of this rut either. You can take that to the bank, too! Some skullduggery is going on here, to be sure!
GLTA!!!
DB, thanks for another good news morsel! But, please someone, anyone, can you tell me why BIEL is still dragging its knuckles in the wake of all this recent good news? Can anyone say flummoxed!
GLTA!!!
DB, I accept most of your posts without comment on the contrary, for they are on point for the most part. But this one, I'm afraid, I would have to register a comment. Of course, the tweet is quick and easy, but I think it would be more professional and effective if BIEL's VP of Sales would use his power of persuasion "de hombre a hombre" regarding the Tiger. Having the Tiger endorse Actipatch would be a big time sales coup, no doubt! Yes, Tiger would want to get paid, and paid pretty handsomely at that. But something probably could be worked out on a contingency basis with the Tiger, if the pie is made sweet enough. Ok! So Sales VP I've given you the roadmap, now let's go "Get Er Done"!
GLTA!!!
Kinda Sad! For Sure! It seems nobody is embarrassed to lie anymore. Apparently, now days, to be thought of as a liar only suggest nothing more than revealing a feature of one's character. However, once upon a time to be looked upon as a liar, would condemn one as having a serious character flaw. But no more, I guess!
GLTA!!!
Kinda! For Sure!
GLTA!!!
By all accounts Actipatch is a very efficacious product and also, transformative industry wise. So, to mess this up, BIEL's brain trust would have to try extremely hard to do so. Regarding the submission to the FDA, if I'm correct, that was announced to happen by the end of this month. Thus, by Friday should be the charm, right? As I have stated in earlier post, the submission in question, should be a "cut & paste" exercise, IMHO. If it doesn't happen by Friday, then it won't be a good look for the folks at BIEL. To be considered honest and truthful is a very valuable commodity, especially in business. If the submission doesn't happen by Friday, then a plausible explanation should be excreted from deep out of the bowels of BIEL's Mahogany Row. I think most know of whom I'm referring.
GLTA!!!
"#1 Stock in ALL of Pinkland. " I've seen this quote more than once on this board. Please, can someone provide the link to quote source.
Thank!
Of course, I'm a BIEL long, and want nothing but the best for the company. But these delaying tactics by the FDA, and apparently with BIEL's collaborate is quite puzzling and disheartening. I can't imagine why BIEL is doing this, but it's kinda obvious they are doing just that! For instance, take this FDA challenge program, IMO BIEL's stature as a legitimate medical device provider is far beyond what that program is trying to accomplish. The way I interpret the aim of the grogram is to help expedite the submission and clearance process for new comers (i.e., device developers still in product development, and those just out of final developmental status, and looking to get FDA ok!). Now BIEL has been in this game for more than 10 years and the FDA has more than a perfunctory idea of what BIEL's product is all about. So, why didn't BIEL just go through the normal channels to get it's product(s) submitted for clearance? I think the normal route would have saved a lot of time, for they already have products cleared. At this juncture, for BIEL shouldn't it be pretty much a procedure of "cut & paste"? Hey! Maybe I'm off the track on this one and is allll wet, as they say, but I don't think so! Nonetheless, GO BIEL!!
GLTA!!!